Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Development and feasibility of the Help to Overcome Problems Effectively (HOPE) self-management intervention for people living with multiple sclerosis.
An investigation of commonly prescribed stretches of the ankle plantarflexors in people with Multiple Sclerosis.
Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons.
Influenza vaccination in patients with multiple sclerosis is possible with some considerations.
Central pontine myelinolysis in a case of alcohol dependence syndrome.
Acute Disseminated Encephalomyelitis After Influenza Vaccination: A Case Report.
Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression.
Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?
Identification of galectin-3 as a possible antibody target for secondary progressive multiple sclerosis.
Re: The effect of venous anatomy on the morphology of multiple sclerosis lesions: a susceptibility-weighted imaging study.
Exercise Effects on Early Vocal Ultrasonic Communication Dysfunction in a PINK1 Knockout Model of Parkinson's Disease.
Regulation of PERK-eIF2α signalling by tuberous sclerosis complex-1 controls homoeostasis and survival of myelinating oligodendrocytes.
Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study.
An attenuated immune response by Schwann cells and macrophages inhibits nerve regeneration in aged rats.
ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis.
Vascular, glial, and lymphatic immune gateways of the central nervous system.
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.
Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy.
Vertebral hemangiomas in the thoracic spine of multiple sclerosis patients are connected with fewer demyelinating lesions at the same level. Possible impact on pathophysiology and clinical course.
Three cases of herpes zoster radiculitis in MS patients treated with natalizumab.
Pathophysiology, assessment and management of multiple sclerosis fatigue: an update.
NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk.
Smoking increases the risk of progression in multiple sclerosis: A cohort study in Queensland, Australia.
Combined Central and Peripheral Demyelination.
[Multiple sclerosis vaccine: possibilities of the use of dendritic cells immunomodulatory potential].
Pages
« first
‹ previous
…
841
842
843
844
845
846
847
848
849
…
next ›
last »